Abstract
Benzimidazole anthelmintic drugs are widely used in veterinary practice. Albendazole sulphoxide (ABZSO) is a benzimidazole drug with two enantiomers, as a consequence of a chiral centre in the sulphoxide group. The kinetics of these enantiomers were studied in male and female sheep. Plasma samples were obtained from the animals between 0.5 and 72 h after oral administration of 7.5 mg/kg of a racemic formulation of ABZSO (total-ABZSO). After a liquid–liquid extraction, the samples were analysed by HPLC to determine the concentrations of total-ABZSO and of the sulphone metabolite (ABZSO2). During the chromatographic analysis, the ABZSO peak was collected and reanalysed by an HPLC technique using a Chiral AGP column to quantify the enantiomeric proportion therein. After kinetic analysis, the AUCs obtained for the (+)-ABZSO were 5.8 and 4.0 times higher than those for the (–)-ABZSO in male and female animals, respectively. The mean residence times were 23.4 and 16.1 h for (+)-ABZSO and 22.2 and 17.4 h for (–)-ABZSO for male and female animals, respectively. The only significant difference between the sexes (p<0.05) was in the T max of the (–)-ABZSO. Comparing both enantiomers within each sex, significant differences were found in all the kinetic parameters. Finally, no kinetic differences were found between sex for total-ABZSO or ABZSO2.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Baggot, J.D. and McKellar, Q.A., 1994. The absorption, distribution and elimination of anthelmintic drugs: the role of pharmacokinetics. Journal of Veterinary Pharmacology and Therapeutics, 17, 409-419
Benoit, E., Besse, S. and Delatour, P., 1992. Effect of repeated doses of albendazole on enantiomerism of its sulfoxide metabolite in goats. American Journal of Veterinary Research, 53, 1663-1665
Berrozpe, J.D., Lanas, J.M. and Pla Delfina, J.M., 1997. Biofarmacia y farmacocinética, Vol. 1, (Editorial Síntesis S.A., Madrid), 167-200
Campbell, W.C., 1990. Benzimidazoles: veterinary uses. Parasitology Today, 6, 130-133
Cristòfol, C., Navarro, M., Franquelo, C., Valladares, J.E., Carretero, A., Ruberte, J. and Arboix, M., 1997. Disposition of netobimin, albendazole, and its metabolites in the pregnant rats: developmental toxicity. Toxicology and Applied Pharmacology, 144, 56-61
Cristòfol, C., Navarro, M., Franquelo, C., Valladares, J.E. and Arboix, M., 1998. Sex differences in the disposition of albendazole metabolites in sheep. Veterinary Parasitology, 78, 223-231
Delatour, P., Benoit, E., Caude, M. and Tambuté, A., 1990a. Species differences in the generation of the chiral sulfoxide metabolite of albendazole in sheep and rats. Chirality, 2, 156-160
Delatour, P., Benoit, E., Garnier, F. and Besse, S., 1990b. Chirality of the sulphoxide of fenbendazole and albendazole in sheep. Journal of Veterinary Pharmacology and Therapeutics, 13, 361-366
Delatour, P., Garnier, F., Benoit, E. and Caude, I., 1991a. Chiral behaviour of the metabolite albendazole sulphoxide in sheep, goats and cattle. Research in Veterinary Science, 50, 134-138
Delatour, P., Benoit, E., Besse, S. and Boukra, A., 1991b. Comparative enantioselectivity in the sulfoxidation of albendazole in man, dogs and rats. Xenobiotica, 21, 217-221
Farrier, D.S., 1997. PK Solutions (ver. 2.0.2): a Noncompartmental Pharmacokinetic Data Analysis Program, (Summit Research Services, 1374 Hillcrest Drive, Ashland, OH 44805, USA)
Gyurik, R., Chow, A., Zaber, B., Bruner, E., Miller, J., Villans, A., Petka, L. and Parish, R., 1981. Metabolism of albendazole in cattle, sheep, rats and mice. Drug Metabolism and Disposition, 9, 503-508
Hennessy, D.R., 1993. Pharmacokinetics disposition of benzimidazole drugs in the ruminant gastrointestinal tract. Parasitology Today, 9, 329-333
Hennessy, D.R., Steel, J.W., Eagleson, G.K. and Prichard, R.K., 1989. The disposition of albendazole in sheep. Journal of Veterinary Pharmacology and Therapeutics, 12, 421-429
Hooper, W.D. and Qing, M.S., 1990. The influence of age and gender on the stereoselective metabolism and pharmacokinetics of mephobarbital in humans. Clinical Pharmacology and Therapeutics, 48, 633-640
Lanchote, V.L., Marques, M.P.C., Takayanagui, O.M., Carvalho, R., Paias, F.O. and Bonato, P.S., 1998. Simultaneous determination of albendazole sulfoxide enantiomers and albendazole sulfone in plasma. Journal of Chromatography B, 709, 273-279
Lanusse, C.E. and Prichard, R.K., 1990. Pharmacokinetics behaviour of netobimin and its metabolites in sheep. Journal of Veterinary Pharmacology and Therapeutics, 13, 170-178
Lanusse, C.E. and Prichard, R.K., 1993. Clinical pharmacokinetics and metabolism of benzimidazole anthelmintics in ruminants. Drug Metabolism Reviews, 25, 235-274
Lanusse, C.E., Nare, B., Gascon, L.H. and Prichard, R.K., 1992. Metabolism of albendazole and albendazole sulphoxide by ruminal and intestinal fluids of sheep and cattle. Xenobiotica, 22, 419-426
Light, D.R., Waxman, D.J. and Walsh, C., 1982. Studies on the chirality of sulfoxidation catalyzed by bacterial flavoenzyme cyclohexanone monooxygenase and hog liver flavin adenine dinucleotide containing monooxygenase. Biochemistry, 21, 2490-2498
Souhaili-El-Amri, H., Fargetton, X., Delatour, P. and Bat, A.M., 1987. Sulphoxidation of albendazole by the FAD-containing and cytochrome P-450 dependent monooxygenases from pig liver microsomes. Xenobiotica, 17, 1159-1168
Souhaili-El-Amri, H., Mothe, O., Totis, M., Masson, C., Batt, A.M., Delatour, P. and Siest, G., 1988. Albendazole sulfonation by rat liver cytochrome P-450. Journal of Pharmacology and Experimental Therapeutics, 246, 758-764
Takahashi, H., Kashima, T., Nomizo, Y., Muramoto, N., Shimizu, T., Nasu, K., Kubota, T., Kimura, S. and Echizen, H., 1998. Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes. Clinical Pharmacology and Therapeutics, 63, 519-528
Villaverde, C., Alvarez, A.I., Redondo, P., Voces, J., Del Estal, J.L. and Prieto, J.G., 1995. Small intestinal sulphoxidation of albendazole. Xenobiotica, 25, 433-441
Waxman, D.J., 1985. Interactions of hepatic cytochromes P450 with steroid hormones. Biochemical Pharmacology, 37, 71-84
Waxman, D.J., Light, D.R. and Walsh, C., 1982. Chiral sulfoxidations catalyzed by rat liver cytochromes P450. Biochemistry, 21, 2499-2507
Whittaker, S.G. and Faustman, E.M., 1991. Effects of albendazole and albendazole sulfoxide on cultures of differentiating rodent embryonic cells. Toxicology and Applied Pharmacology, 109, 73-84
Witkamp, R.F., Nijmeijer, S.M., Mennes, W.C., Rozema, A.W., Noordhoek, J. and Van Miert, A.S., 1983. Regioselective O-demethylation of scoparone (6,7-methoxycoumarin) to assess cytochrome P450 activities in vitro in the rat. Effects of gonadal steroids and the involvement of constitutive P450 enzymes. Xenobiotica, 23, 401-410
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Capece, B., Castells, G., Pérez, F. et al. Pharmacokinetic Behaviour of Albendazole Sulphoxide Enantiomers in Male and Female Sheep. Vet Res Commun 24, 339–348 (2000). https://doi.org/10.1023/A:1006496122684
Issue Date:
DOI: https://doi.org/10.1023/A:1006496122684